What impact will Brexit deal have on radiology?

The recent announcement from McKesson of plans to spin-off a large portion of its health IT business came as little surprise. McKesson's health IT business has long been the side project to the $188B pharmaceuticals distribution arm; with competition in the North America market intensifying (around 90% of McKesson customer base), significant investment was going to be required to continue to compete.

Processing speed has increased, advanced visualisation has become more complex, and access has improved, but little has changed for the most part.

There are less than six months to go until the U.K. officially “leaves” the European Union (EU). But are we any clearer on what this will mean for medical imaging? Having taken a deep breath and dug into some of the technical guidance papers issued recently by the U.K. Government, I can confirm that unfortunately there’s not a great deal of positive news to report.